Seattle Cancer Care Alliance, now Fred Hutchinson Cancer Center, the only National Cancer Institute (NCI)-designated cancer center in Washington, will have more than 20 clinicians presenting at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting from June 3-7, 2022 in Chicago.
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.
Seattle Cancer Care Alliance (SCCA), the only NCCN-designated cancer center in Washington State, has been selected as an authorized treatment center for the new chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel, also known as liso-cel and by the brand name BreyanziTM. Liso-cel was approved by the U.S. Food and Drug Administration (FDA) on February 5, 2021.
Seattle Cancer Care Alliance (SCCA), the only National Comprehensive Cancer Network (NCCN)-designated cancer center in Washington state, has been selected as an authorized treatment center to offer brexucabtagene autoleucel, also known by the brand name TecartusTM. It is the first and only chimeric antigen receptor (CAR) T-cell therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL).
Seattle Cancer Care Alliance (SCCA), committed to delivering patient-centered, high-quality cancer care as the only NCCN-designated cancer center in Washington State, announced that members of its clinical nursing staff will participate in 10 poster presentations during the 2020 Oncology Nursing Society (ONS) Bridge Virtual Conference. The meeting is being held September 8, 10, 15 and 17, 2020.
Seattle Met, a monthly magazine that reports on Seattle politics, arts and community, released its annual Top Doctors list today, featuring 68 Seattle Cancer Care Alliance (SCCA) doctors, physician assistants and nurse practitioners.
UWMC/ Seattle Cancer Care Alliance (SCCA), part of Washington state’s only National Cancer Institute (NCI)-designated comprehensive cancer center, has been recognized as the 9th Best Cancer Hospital for 2020-21 by U.S. News & World Report, and the only ranked number one cancer hospital in the Pacific Northwest for more than ten years. The annual Best Hospitals rankings and ratings, now in their 31st year, are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions or for common elective procedures.
Seattle Cancer Care Alliance (SCCA) announced that Paula Rosput Reynolds will become chair of its Board of Directors. Reynolds takes the helm of the SCCA board from Karen Glover, who served as chair since 2018.
Seattle Cancer Care Alliance (SCCA) announced the beginning of construction on its South Lake Union (SLU) campus to add a new six-story, 150,000 square-foot outpatient cancer treatment clinic.
Genitourinary cancer specialists from Seattle Cancer Care Alliance, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, and Weill Cornell Medicine have published an article , “Reconsidering the Trade-offs of Prostate Cancer Screening,” in the New England Journal of Medicine on the long-term benefits of prostate-specific antigen (PSA) screening for prostate cancer in men. In the article, investigators concluded that the advantages of widespread screening – including reduced mortality and the potential to avoid metastases – are likely greater than estimates cited in current guidelines.
During a plenary session of the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program, findings will be presented from the global phase III JAVELIN Bladder 100 randomized study conducted by investigators from Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center and University of Washington Medicine along with several other research centers. The results demonstrated significantly prolonged overall survival of patients with locally advanced (unresectable) or metastatic urothelial cancer when treated with first-line immunotherapy avelumab plus best supportive care (BSC) compared to BSC alone (following disease control on induction chemotherapy).
Fred Hutchinson Cancer Research Center and its clinical-care partner, Seattle Cancer Care Alliance, announced today the organizations are receiving a $500,000 grant from Bank of America for COVID-19 relief.
Seattle Cancer Care Alliance (SCCA) announced today that Aaron Crane is the Alliance’s new Executive Vice President. Crane will lead the organization’s strategic development, including SCCA’s long-range financial plan and the upcoming clinic expansion at SCCA’s South Lake Union campus.
News and interview opportunities at Seattle Cancer Care Alliance
Interested in learning more about any of the updates described below? Contact us at [email protected]
On September 19 and 20, 2019, SCCA will celebrate its second Immunotherapy Symposium in Seattle, WA.
More than 20 physicians and researchers from Seattle Cancer Care Alliance (SCCA) will present at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL May 31 – June 4, 2019.
Inspired by its 2016–2019 Community Benefit Strategic Implementation Plan, Seattle Cancer Care Alliance (SCCA) today announced three community benefit grant recipients: Stilly Valley Health Connections, Cierra Sisters and the Korean Women’s Association.
Seattle Cancer Care Alliance is opening two new patient care centers in Issaquah, WA and in Poulsbo, WA.
The Fred Hutch Bone Marrow Transplant (BMT) Program at Seattle Cancer Care Alliance (SCCA) has once again earned national recognition for outperforming expected one-year survival rates, for the sixth consecutive year.
Seattle Cancer Care Alliance (SCCA) / University of Washington Medical Center (UWMC) is ranked among the best in the nation for adult cancer care by U.S. News & World Report for 2018-2019.
Seattle Cancer Care Alliance (SCCA) is one of eight national recipients of an Employer of Excellence award from the American Academy of Physician Assistants (PA’s) Center for Healthcare Leadership and Management.
Seattle Cancer Care Alliance (SCCA) recently opened the Hematologic Malignancy Genetics Clinic, which provides personalized risk assessment and follow-up care for adult patients and family members who may be at increased risk for developing hematologic malignancies due to an underlying genetic cause.
Seattle Cancer Care Alliance Medical Director F. Marc Stewart, MD received a silver “Outstanding Medical Director” award from Seattle Business magazine. The award was presented at the magazine’s ninth annual Leaders in Health Care Awards event, held in Seattle at Bell Harbor Convention Center on March 1.
Long-time Seattle Cancer Care Alliance oncology nurse will be inducted as a Fellow by the American Academy of Nursing on October 7.
For more than a decade, SCCA/UWMC consistently has maintained a top standing among the top hospitals for adult cancer care in the U.S.
Seattle Cancer Care Alliance (SCCA) announced today that the American Academy of Nursing has selected Kathleen Shannon Dorcy, PhD, RN, Director, Clinical Nursing Research, Education and Practice, as an Academy Fellow.
Seattle Cancer Care Alliance experts are available to discuss new U.S. Preventive Services Task Force guidelines related to thyroid cancer screening for adults, risk factors and treatment options.
Machine learning (or coding) could help reduce false positives from mammography screening, according to an article study published online in the May 4, 2017 issue of the Journal of the American Medical Association (JAMA) Oncology. The national coding competition known as the DREAM Challenge, launched during the inauguration of Vice President Biden’s Cancer Moonshot Challenge, may help mitigate this harm associated with routine screening.
Seattle Cancer Care Alliance (SCCA) is thrilled to welcome Dr. Theresa M. McDonnell as the Alliance’s new Chief Nurse Executive, Vice President of Clinical Operations. She will be responsible for overseeing all nursing staff, guiding patient care delivery, ensuring staff accountability for providing a patient-centered clinical practice environment, and overseeing general clinical quality and patient safety.
The American Association for Cancer Research, or AACR, announced that Seattle Cancer Care Alliance’s Dr. Nancy Davidson, an internationally acclaimed breast cancer oncologist, is among its newly elected class of Fellows of the AACR Academy.
The Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance has earned recognition by the Center for International Blood and Marrow Transplant Research for outperforming its expected one-year survival rates for allogeneic transplant patients – those who receive donated adult blood-forming stem cells.
Hawaii Pacific Health has joined the Seattle Cancer Care Alliance Affiliate Network. SCCA has 13 Affiliate Network partners located across the Western U.S., including in Alaska, Idaho, Montana, Oregon, Washington, and now Hawaii.
SEATTLE – (Sept. 20, 2016) – Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve patients with prostate cancer that has spread beyond the prostate (metastatic) and/or who have a family history of the disease or a family history of breast cancer, ovarian cancer, pancreatic cancer, lymphoma or leukemia. These men are more likely to have an inherited and more aggressive form of prostate cancer. Knowing a patient has a particular genetic mutation helps doctors choose the best treatment plan and can open doors for innovative clinical trials.
Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve patients with prostate cancer that has spread beyond the prostate (metastatic) and/or who have a family history of the disease or a family history of breast cancer, ovarian cancer, pancreatic cancer, lymphoma or leukemia. These men are more likely to have an inherited and more aggressive form of prostate cancer. Knowing a patient has a particular genetic mutation helps doctors choose the best treatment plan and can open doors for innovative clinical trials.
The April 19, 2016 issue of The Journal of the American Medical Association (JAMA) features an editorial by two Seattle Cancer Care Alliance (SCCA) medical oncologists who specialize in melanoma: Dr. Shailender Bhatia and Dr. John Thompson. Their editorial addresses the state of immunotherapy drugs, specifically PD-1 blockade, in the treatment of melanoma.
Following the success of its recent brand relaunch, Seattle Cancer Care Alliance (SCCA) will kick off its 2016 advertising campaign with a television commercial debuting during the Seattle area broadcast of the Super Bowl on Sunday, Feb. 7, on CBS affiliate KIRO-TV. Three additional TV ads will air in the weeks after, and all will run through June. The campaign is designed to convey the strength of SCCA’s three alliance partners—Fred Hutchinson Cancer Research Center, Seattle Children’s and UW Medicine—and how “Better Together” translates into better outcomes for patients in the treatment of cancer.
The Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance (SCCA) has earned recognition by the Center for International Blood and Marrow Transplant Research for outperforming its expected one-year survival rates for allogeneic transplant patients – those who receive donated adult blood-forming stem cells. This recognition is held by only 17 of 173 stem cell transplant programs nationwide.
Seattle Cancer Care Alliance relaunches its brand to reiterate founding partner strength and commitment to patient care.
Seattle Cancer Care Alliance/University of Washington Medical Center has been named as one of the top five Best Hospitals in the Nation for Adult Cancer Treatment by U.S. News & World Report for 2015-2016.
The Fred Hutchinson Cancer Research Center Bone Marrow Transplant Program at Seattle Cancer Care Alliance (SCCA) was recently recognized for outperforming its anticipated one-year survival rate for allogeneic transplant patients. The new performance results were calculated by the Center for International Blood and Marrow Transplant Research (CIBMTR) and published in the 2014 Transplant Center-Specific Survival Report. The annual report is designed to provide potential stem cell transplant recipients, their families, and the public with comparative survival rates among transplant centers. This is the second consecutive year the Fred Hutch Bone Marrow Transplant Program at SCCA has achieved higher than expected one-year survival rates, an accomplishment that only 12 other institutions have achieved.
Inspired by its Community Health Needs Assessment (CHNA) 2012-2015 report, Seattle Cancer Care Alliance (SCCA) recently launched a health improvement grant program. The new community program addresses specific cancer screening, early detection, and prevention needs for at risk populations in King, Snohomish, and Pierce counties. Designed to build sustainable collaborations with Washington communities, SCCA selected seven local nonprofit organizations to receive funds. The SCCA Community Health Improvement Grant program awarded funds up to $7,500 to grantees.
Katmai Oncology Group has joined the Seattle Cancer Care Alliance (SCCA) Network to become its eleventh affiliate in the greater Northwest. The affiliation will expand local access to cancer treatment options and help foster advances in cancer care.
In 2014, more than 200,000 new cases of invasive breast cancer will be diagnosed in women in the United States, and about 40,000 of them will die, according to the American Cancer Society. While many types of breast cancer are curable, conventional treatment methods can expose the heart, lungs, and other organs to radiation resulting in an increased risk of side effects such as coronary artery disease, lung scarring, and secondary malignancies. Side-effects are especially common in patients with reoccurring cancers as their bodies are subjected to multiple rounds of treatment.
As of October 2014, 19 states have enacted laws requiring women to be directly informed if they have dense breasts and would benefit from supplemental screening. However, the recommended type of supplemental screening for women with dense breasts remains unclear. With 15 additional states considering similar laws and federal legislation introduced, physician scientists at the University of Washington and Seattle Cancer Care Alliance (SCCA) investigated the potential impact of supplemental screening for women with dense breast tissue. The study’s findings are published this month online in the journal Radiology.
Seattle Cancer Care Alliance (SCCA) is participating in the Seattle/King County Clinic with Remote Area Medical (RAM). The team will be offering free mammogram and cancer screening services with instantaneous results. More than 50 health, human service, and civic organizations from across the State of Washington are joining together to produce a giant free health clinic. In partnership with the humanitarian organization Remote Area Medical (RAM), the four-day volunteer-driven clinic provides a full range of free dental, vision, and medical care to undeserved and vulnerable populations in the region.
Today Seattle Cancer Care Alliance (SCCA) was recognized as a ‘Leader in LGBT Healthcare Equality’ by the Human Rights Campaign (HRC) Foundation in its 2014 Healthcare Equality Index. The annual survey encourages equal care for LGBT Americans, and recognizes health care institutions doing the best work. SCCA earned top marks in meeting non-discrimination and training criteria that demonstrate its commitment to equitable, inclusive care for LGBT patients and their families, who can face significant challenges in securing the quality health care and respect they deserve.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right